Schedule 13G ownership disclosure
PTC Therapeutics Inc
Security class unavailable · CUSIP: 69366J200
Event date: 2016-09-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.8400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001654954-16-002457
- Form type
- SC 13G
- Filer
- Camber Capital Management LP
- CIK
- CIK 1444043
- Filed
- Sep 29, 2016
- Reporting period
- Sep 19, 2016
- Description
- Schedule 13G beneficial ownership